Relapse Prevention Study in Patients With Schizophrenia
Clinical trial NCT01291511 · COMPLETED
Trial details
- NCT number
- NCT01291511
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2014-03-01
- Enrollment
- 635
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.